Tarsus Pharmaceuticals, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €157.81M +948.6% -€99.68M -15.0% -63.2% +7.2 pp -€70.27M -29.8% -44.5% +6.2 pp
    €15.05M -32.4% -€117.22M +118.9% -778.9% -5.4 pp -€100.05M +139.0% -664.8% -4.8 pp
    €22.27M -54.7% -€53.56M +349.1% -240.5% -2.2 pp -€41.86M -1,219.6% -188.0% -2.0 pp
    €49.19M +∞% -€11.93M -48.4% -24.2% -0.24 pp €3.74M -121.0% 7.6% +0.076 pp
    €0.00 +NaN% -€23.13M +474.1% N/A -€17.84M +491.3% N/A
    €0.00 +NaN% -€4.03M +254.1% N/A -€3.02M +197.4% N/A
    €0.00 -€1.14M N/A -€1.01M N/A

    Notifications